Bms Financial Advisors, LLC Repligen Corp Transaction History

Bms Financial Advisors, LLC

  • $148 Million
  • Q2 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023
SELL
$162.42 - $220.56 $9,907 - $13,454
-61 Reduced 3.99%
1,469 $0
Q3 2022

Oct 17, 2022
BUY
$160.42 - $256.21 $6,256 - $9,992
39 Added 2.62%
1,530 $286,000
Q2 2022

Jul 11, 2022
BUY
$140.68 - $188.02 $11,254 - $15,041
80 Added 5.67%
1,491 $242,000
Q1 2022

May 11, 2022
BUY
$161.19 - $257.96 $21,277 - $34,050
132 Added 10.32%
1,411 $265,000
Q4 2021

May 11, 2022
BUY
$247.59 - $304.47 $316,667 - $389,417
1,279 New
1,279 $339,000

Others Institutions Holding RGEN

# of Institutions
485
Shares Held
54.1M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Bms Financial Advisors, LLC Portfolio

Follow Bms Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bms Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bms Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email